Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | 252.00K | 114.40K | 138.30K | 100.30K | 213.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 252.00K | 114.40K | 138.30K | 100.30K | 213.80K |
| Cost of Revenue | 38.20K | 84.30K | 30.90K | 99.70K | 39.40K |
| Gross Profit | 213.80K | 30.10K | 107.30K | 600.00 | 174.40K |
| SG&A Expenses | 299.20K | 274.30K | 369.10K | 380.20K | 174.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 337.40K | 358.60K | 400.00K | 479.90K | 213.70K |
| Operating Income | -85.50K | -244.20K | -261.70K | -379.60K | 100.00 |
| Income Before Tax | -283.70K | -332.60K | -505.90K | -7.26M | 100.00 |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -283.70K | -332.60K | -505.90K | -7.26M | 100.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -283.70K | -332.60K | -505.90K | -7.26M | 100.00 |
| EBIT | -85.50K | -244.20K | -261.70K | -379.60K | 100.00 |
| EBITDA | -82.90K | -242.00K | -259.70K | -378.00K | 1.40K |
| EPS Basic | -0.01 | -0.01 | 0.00 | -0.02 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | -0.02 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 49.14M | 49.14M | 150.75M | 334.17M | 330.48M |
| Average Diluted Shares Outstanding | 49.14M | 49.14M | 150.75M | 334.17M | 330.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |